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PREVIOUS studies in this laboratory have suggested that the relative sensitivi-
ties of coexistent normal and tumour cell populations to cytotoxin, are deternlined
by their respective replication kinetics (Hoffman and Post, 1966). Thus the
carcinogen-induced polyploid rodent heptoma cells had longer generation and
DNA synthesis times than did normal diploid hepatocytes (Post and Hoffman,
1964), or coexistent ileal cells (unpublished observations). In addition, the cells
of the carcinogen-induced rodent diploid breast tumour had longer replication
and DNA synthesis times than did coexistent diploid ileal cells. The incorporation
ofthe tritiated antimetabolite, 5-iodo-2'-deoxy-uridine (IUDR-3H), was greater by
the more rapidly multiplying ileal cells, than by the breast tumor cells. In addi-
tion, the percentage of ileal cells which incorporated IUDR-3H was greater than
that of the tumor cell population (Hoffman and Post, 1966).
The present report extends these studies to a third autogenous rodent tumor,
the methylcholanthrene-induced sarcoma of connective tissue. The data show
that these aneuploid, polyploid tumor cells also gave longer generation and DNA
synthesis times than their coexistent ileal cells. In addition, larger amounts of
IUDR-3H are incorporated by the more rapidly replicating ileal cells and by a
larger percentage of their population than by tumor cells.
METHODS
Three-weeks-old male Wistar rats were injected subcutaneously in the posterior
nuchal area, with 30 mg. of 3-methylcholanthrene dissolved in 1 ml. of corn oil.
About 4 months later, when these tumors exceeded 1-5 cm. in diameter, each rat
received 50 ,tCi of tritiated thymidine (TDR-3H), S.A. 0.36 Ci/m-mole (Schwarz
Bio Research, Orangeburg, N.Y.), subcutaneously. At frequent intervals
thereafter, they were killed and samples of ileum and of tumor were fixed in 9500
ethyl alcohol-glacial acetic acid (3: 1). Autoradiographs were prepared from
5 It Feulgen-stained sections, dipped in NTB3 emulsion, and incubated for 30 days
in the cold. In each specimen the labeling of 50 or more mitoses was scored. The
estimations of the replication cycles were based upon the changing percentages
of labeled metaphase mitoses with time (Quastler and Sherman, 1959). The data
for each animal have been plotted and " best fit " curves have been drawn through
the respective means. The generation time was estimated from the time of
initiation of labeling in the first and second cycles. The time for DNA synthesis
was that interval between the 500o labeling intercepts of the ascending and
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calculated as the time when 5000 ofall mitoses were labeled. G1 was estimated by
subtracting the sum of the times for DNA synthesis and G2+ mitosis from the
generation time. The percentages of mitoses and of interphase labeling were
determined from the scanning ofat least 5000 cells in ileum and tumour, in each of
3 rats, 2 hours after TDR-3H administration.
Grain counts were made over at least 100 labeled interphase nuclei per rat at
the indicated times, in order to follow the continuity of a particular labeled cohort
of cells through successive replication cycles. Each of 3 tumor-bearing rats
received 1 ,uCi/g. 5-IUDR-3H, S.A., 0.744 Ci/m-mole (Nuclear Chicago, Chicago,
Ill.), subcutaneously and was killed after 2 hours. Autoradiographs were prepared
in the manner described above. The percentages of 5-IUDR-3H labeled cells in
the tumor and in the ileal populations were determined from scanning at least
5000 nuclei in each rat. The incorporation of the antimetabolite was estimated
from the grain counts of 100 or more interphase nuclei, per specimen of ileum and
tumor.
The ploidy classes of the interphase nuclei of the tumor and of villous ileal
cells were determined by the 2 wave-length spectrophotometric method, in
Feulgen-stained sections (Ornstein, 1952; Patau, 1952).
In no case were necrotic tumors included in these studies.
RESULTS
Sarconma cells
The tumor consists of pleomorphic cells growing in sheets. They invade the
local subcutaneous and muscle tissue, but do not metastasize to distant areas.
They may grow to 4 cm. in diameter, rupture through skin and become necrotic.
The cells of this tumor are aneuploid and polyploid. The percentage of labeled
interphase tumor cells 2 hr. after TDR-3H is 4.8, and 0.6% of these cells are in
mitosis (Table I).
The curve ofmetaphase labeling is a broad one (Fig. 1). The generation time is
about 40-0 hr., DNA synthesis 24-0 hr., G2+ mitosis 1-5 hr. and G1 14.5 hr. One
complete cycle and part of the second are observed. After 60 hr. the label
becomes too dilute to permit the scoring of labeled mitoses. The mean grain
counts and their probable errors, 2 and 48 hr. after TDR-3H, are 7.2 ± 0.09 and
4.0 ± 0.10, respectively.
Ileal cells
The metaphase labeling curve describes 2 cycles and thereafter the label
becomes too dilute for continued scoring (Fig. 2). The generation time is about
11-0-12.0 hr., DNA synthesis 7 hr., G2+ mitosis 1.0 hr. and G1 3-0-4-0 hr. The
percentage of labeled interphase ileal cells is 37.2 and 6-7% are in mitosis. The
mean grain counts and their probable errors, 2 and 32 hr. after TDR-3H, are
14.8±0 15 and 7-0±0 10, respectively (Table I).
5-IUDR-3H Incorporation
Estimates of the percentages of tumor and of ileal cells labeled by the anti-
metabolite are 11.4 and 51.6, respectively. The mean grain counts and their
probable errors are 11*1 ± 0.20 for tumor cells, and 20.2 ± 0.70 for ileal cells
(Table I).
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FIG. I.-Metaphase labeling of sarcoma cells. The curve shows 1 cycle and part of a second.
The generation time is about 40 hours and DNA synthesis 24 hours.
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FIG. 2.-Metaphase labeling of ileal cells. The curve shows 2 cycles. The first cycle generation
time is about 11.0-12.0 hours and DNA synthesis 7 hours.
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DISCUSSION
The object of effective cancer chemotherapy is the destruction of cancer cells
while sparing normal cells. It is implied that cancer cells multiply more rapidly
than do normal cells and that this difference may be exploited biochemically by the
interposition of a cytotoxin. However, the clinical experience with cancer
chemotherapy has been that whether or not a given cytotoxin affects tumor cells,
it is usually toxic for replicating normal cells, notably the hematopoietic and
gastrointestinal systems (Dustin, 1963). Indeed, the usefulness of antitumor
agents has been limited by the level of tolerance of the tumor-bearing host to the
destruction of these normal cell populations.
The data from the 3 autogenous tumours studied in this laboratory show that
while their respective cell populations differ from each other in the several time
compartments ofthe generation cycle, in each instance their replication and DNA
synthesis times arelongerthan arethose ofthe coexistentnormalileal cells (TableI).
In addition much larger percentages of the ileal cell populations are engaged in
DNA synthesis. The results of recent investigations of coexistent human cancer
and normal cells, in vivo, support the conclusion that the rates ofDNA synthesis of
normal diploid lymphocytes and gastrointestinal cells are higher than those of
several coexistent diploid and polyploid tumor cell populations. The percentages
of normal cells in DNA synthesis are usually higher than those of the tumor cells
(Hoffman and Post, 1967). These data are in accord with those of other authors
who found relatively slow generation and DNA synthesis times for human tumor
cells (Baserga, 1965; Clarkson et al., 1965; Clarkson et al., 1967; Killmann et al.,
1961; Killmann et al., 1962). Thus, the available evidence indicates that auto-
genous tumor cells multiply more slowly than do coexistent replicating normal
cells.
In contrast, transplanted tumor cells, which are usually employed for testing
antitumor chemicals, have relatively short generation times (Baserga, 1963;
Edwards et al., 1960; Goldfeder, 1965), similar to those for intestinal cells. With
successive transplantations their growth rates may increase (Steel, Adams and
Barrett, 1966).
In the normal mouse the highest levels of incorporation of IUDR-131I were in
those cells which were actively proliferating, i.e. bone marrow, intestine and
spleen (Hughes et al., 1964). In other reports it was found that the intestinal
cells incorporated more antimetabolite than did cells of transplanted lymphomas
(Clifton et al., 1963; Prusoff, Jaffe and Gunther, 1960) or autogenous mammary
tumors (Rotenberg, Bruce and Baker, 1962). The replication times of these
mouse tumor cells were not reported.
The relationship of antimetabolite incorporation into DNA, to cell replication
kinetics, is clearly demonstrated by the data ofthe rodent breast tumor (Hoffman
and Post, 1966) and of the sarcoma cells. The incorporation of 5-IUDR-3H is
greater by ileal cells, with their shorter DNA synthesis times than by the cells
of either the connective tissue sarcoma or breast tumor (Hoffman and Post, 1966)
(Table I). From considerations of their respective replication times, it is evident
that at a sustained level of circulating antimetabolite about 3-4 cycles of ileal
cells would be exposed thereto for every cycle of tumour cells. The population
per cent of ileal cells exposed would be 5-7 times greater than of tumor cells.
Thus, the predilection of toxicity for multiplying normal cells, as compared to
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coexistent tumor cells, may be attributed to the replication kinetics of the specific
populations. Accordingly, the limits of usefulness of cancer chemotherapy may
be defined by these latter differences between normal and tumor cells.
SUMMARY
The replication kinetics of the methylcholanthrene-induced rodent connective
tissue sarcoma and ofcoexistent ileal cells have been studiedin vivo, usingTDR-3H
labeling and autoradiography. The results show that the generation time of the
tumor cells is about 4 times as long as that ofileal cells. In addition, the percent-
age of ileal cells engaged in multiplication is 7 times that of tumor cells. The
incorporation of the labeled antimetabolite, 5-IUDR-3H, by ileal cells is greater
and by a larger percentage of their population. The results confirm previously
published studies from this laboratory on the replication kinetics of autogenous
tumor cells and their relationships to antimetabolite incorporation. The pre-
dilection of toxicity for normal cells, as compared with coexistent tumor cells, is
ascribed to the more rapid replication of the normal cells.
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